February Market Analysis of Raw Materials for Veterinary Medicines
VPI is stable, the market restarts slowly after the holiday, and a wait-and-see mentality is strong, waiting for changes in the market to choose.
1. Data monitoring, the veterinary drug raw material price index (VPi) on February 9 was 90.15, which was consistent with the pre-holiday performance. After the holiday, the market performance was average, and the purchase of just-needed goods recovered steadily. The quotations in the middle and upper reaches remain stable, and the market has a strong wait-and-see attitude, waiting for changes in the market outlook.
2. After the Spring Festival, the market news was quiet, and the overall trading atmosphere was deadlocked. Although there are some areas, the supply of spot circulatable goods is tight, traders are reluctant to sell, and the offer is slightly pushed up. However, the festive atmosphere has not subsided, and the market has entered an obvious wait-and-see stage.
Under this background, it is difficult for the market to discuss the news, and the market continues to be cold. In the short term, the pull from the external environment and cost is small, and the firm transaction situation will continue to follow up. In addition, it is still necessary to pay close attention to factory news and downstream purchasing sentiment.
3. Raw materials for veterinary drugs: The market performance after the holiday is average, and the downstream demand is gradually recovering. Due to insufficient stocking before the holiday, the probability of inquiries after the holiday is high. Most of the mainstream categories maintained the price trend before the holiday, waiting for a clear signal from the market.
After the holiday, the market transaction prices of doxycycline hydrochloride and florfenicol were stable and weak; the prices of penicillin potassium industrial salt and amoxicillin were high, and the market was reluctant to sell, and the prices followed strong; Restricted, market attention is high, and trade channel inquiries are active, so please pay attention.
4. Vitamins: The vitamin market has not yet fully opened after the holiday, and the performance is stable. The pre-holiday atmosphere continues, and the overall demand is weak.
The upstream market is stabilizing and waiting for the market, with a wait-and-see attitude, and corresponding price adjustments according to changes in downstream demand. At the same time, downstream demand is relatively weak, mainly consuming inventory. For calcium pantothenate, VB6 and other varieties, it is necessary to pay more attention to the quotations of various factories.
Please continue to pay attention to the market situation, and grasp business opportunities according to the actual situation.
Looking for chemical products? Let suppliers reach out to you!
2026-07-18
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Australia intends to establish a maximum residue limit for flufenamidonitrile in broad beans
-
Analysis of the Chinese Veterinary Drug Raw Material Market in the 33rd Week of 2022
-
Analysis of The Domestic Veterinary Drug Raw Material Market In The Seventh Week of 2022-2
-
Florfenicol 570, Down Over 8%, Tilmicosin Down Over 4%...
-
The Average Prices of Tylosin Tartrate And Tilmicosin Dropped by 12.33% And 10.31% From Their Highs During The Year
-
Market analysis of veterinary drug feed ingredients
-
Market analysis of veterinary drug feed ingredients
-
The peak season is approaching, the veterinary raw material drug market may rebound!
-
The price of veterinary raw materials has jumped, what is the reason?
-
Market Analysis - Monthly Report - August, 2020 - Florfenicol
Recommend Reading
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
Weak Balance Under Cost Support—Melamine Market Struggles to Stay Firm
-
Positive Factors Support January Price Increase of Cyclohexanone in Shandong by Nearly 9%
-
China's Acetone Market Reverses Decline and Rises
-
What are Acetoglycerides? (Definition & Food Industry Uses)
-
What is Aconitic Acid? (Chemistry & Occurrence)